Internal Medicine, Infectious Disease · Spring Hill, FL
NPI
1750562724
Since 2007
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
4
Medicare group memberships
Hospitals
2
Hospital affiliations
12120 Cortez Blvd
Spring Hill, FL, 34613
Phone (352) 559-8849
Groups this clinician bills Medicare through
Medicare paid, 2024
$136K
1,933 services
Medicare patients, 2024
415
Average age 77
Drug cost, 2024
$270K
907 prescriptions
Company payments, 2025
$16.7
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Guesly J Delva was code 99232 (hospital e&m - subsequent), 1,472 times for 310 patients. In total Guesly J Delva billed 1,933 services in 14 codes, and Medicare paid $136K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-09-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 1,472 | 310 | $61.36 | $90K |
| 99222 Hospital E&M - Initial | Facility | 207 | 180 | $102.18 | $21K |
| 99223 Hospital E&M - Initial | Facility | 105 | 102 | $133.22 | $14K |
| 99213 Office E&M - Established | Office | 66 | 53 | $64.38 | $4,249 |
| 99214 Office E&M - Established | Office | 18 | 18 | $68.17 | $1,227 |
| 99203 Office E&M - New | Office | 17 | 17 | $81.36 | $1,383 |
| 99212 Office E&M - Established | Office | 16 | 15 | $42.42 | $679 |
By year: 2022 $165K for 2,291 services; 2023 $187K for 2,609 services; 2024 $136K for 1,933 services.
Medicare prescription drug claims, 2024
In 2024, the drug Guesly J Delva prescribed most often to Medicare patients was Vancomycin Hcl, with 180 prescriptions and refills. In total Guesly J Delva wrote 907 Medicare prescriptions that cost $270K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Vancomycin Hcl Generic | 180 | 181 | 54 | $35K |
| Cefepime Hcl Generic | 130 | 130 | 44 | $27K |
| Meropenem Generic | 108 | 108 | 44 | $20K |
| Ceftriaxone Ceftriaxone Sodium | 96 | 96 | 32 | $18K |
| Daptomycin Generic | 95 | 95 | 29 | $77K |
| Cefazolin Sodium Generic | 40 | 40 | Under 11 | $1,660 |
| Ertapenem Ertapenem Sodium | 36 | 36 | 13 | $22K |
| Piperacillin-Tazobactam Piperacillin Sodium/Tazobactam | 23 | 23 | Under 11 | $4,154 |
| Micafungin Micafungin Sodium | 22 | 22 | Under 11 | $10K |
| Diphenhydramine Hcl Generic | 20 | 20 | 16 | $70.54 |
| Ampicillin Sodium Generic | 20 | 20 | Under 11 | $4,630 |
| Ampicillin-Sulbactam Ampicillin Sod/Sulbactam Sod | 18 | 18 | Under 11 | $4,258 |
| Cefdinir Generic | 13 | 13 | 12 | $153 |
Brand drugs: 40 claims; generic drugs: 867 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Guesly J Delva $16.7 ($16.7 in general payments such as food, travel and fees) from 1 company. The largest payer was ViiV Healthcare Company with $16.7.
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company GSK | 1 | $16.7 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.